**Professional Affiliations:** 1. Member, 19th National Committee, Chinese Medical Association, Surgery Branch 2. Vice Chairman, Neuroendocrine Tumor Professional Committee, Chinese Anti-Cancer Association 3. Vice Chairman, Medical Robot Development Promotion Branch, China Medical Education Association 4. Vice Chairman, Biliary Tract Tumor Professional Committee, Chinese Chapter of the International Hepato-Pancreato-Biliary Association 5. Deputy Head, Robot Surgery Expert Working Group, Surgeon Branch, Chinese Medical Doctor Association 6. Standing Committee Member, Pancreatology Committee, Chinese Research Hospital Association 7. Chairman, Surgery Branch, Guangdong Medical Association 8. Vice Chairman, Pancreatology Professional Committee, Guangdong Medical Doctor Association 9. Chairman, Hepatobiliary and Pancreatic Surgery Professional Committee, Guangdong Provincial Clinical Medical Association 10. Vice Chairman, Pancreatic Cancer Professional Committee, Guangdong Anti-Cancer Association 11. Chairman, Biliary Tract Tumor Professional Committee, Guangdong Anti-Cancer Association 12. Deputy Editor-in-Chief, *Chinese Journal of Experimental Surgery*; Editorial Board Member, *Gastroenterology Report*, *Chinese Journal of Hepatobiliary Surgery*, *Chinese Journal of Digestive Surgery*, *Chinese Journal of Pancreatology*, *Chinese Journal of General Surgery (Electronic Edition)*, and other journals. **Publications:** The author has published over 150 papers as first author and/or corresponding author in SCI journals including *Advanced Science* (IF=14.3), *ACS Nano* (IF=15.3), *Cancer Communications* (IF=20.1), *Cell Death and Differentiation* (IF=13.7), *Molecular Therapy* (IF=12.1), *Cancer Letters* (IF=9.1), *Oncogene* (IF=6.9), *Int J Biol Sci* (IF=8.2), *Clin Trans Med* (IF=7.9), *Applied Materials Today* (IF=7.2), *Br J Surg* (IF=8.6), as well as in domestic core journals such as *Chinese Journal of Surgery*, *Chinese Journal of Digestive Surgery*, *Chinese Journal of Hepatobiliary Surgery*, and *Chinese Journal of Practical Surgery*. Selected recent publications are listed below: 1. Yangyinhui Yu, Qiongcong Xu, Jinzhao Xie, Mingjian Ma, Xitai Huang, Yinhao Shi, Jiawei Zhou, Enliang Zhu, Ziyi Zhao, Ning Zhang, Zhide Liu, Jingyuan Ye, Xiaoyu Yin. Calcium Channel Blockers Inhibit Pancreatic Neuroendocrine Neoplasms Progression via Cav1.2-Epigenetic Circuit. *Adv Sci (Weinh)*. 2026 Feb 4:e16733. doi: 10.1002/advs.202516733. (Corresponding author) 2. Ai-Qing Fu, Xi-Tai Huang, Jian-Peng Cai, Chen-Song Huang, Xin Zhang, Qiong-Cong Xu, Wei Chen, Liu-Hua Chen, Xiao-Yu Yin. Factors associated with textbook outcome after robotic-assisted pancreatoduodenectomy: a single surgeon’s retrospective cohort. *HepatoBiliary Surg Nutr* 2025. https://dx.doi.org/10.21037/hbsn-24-547. (Corresponding author) 3. Si-Yuan Lu, De-Liang Fang, Zi-Yi Zhao, Ying-Qin Zhu, Zhi-De Liu, Ming-Jian Ma, Jing-Yuan Ye, Qiong-Cong Xu, Xiao-Yu Yin. Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcinoma. *Cancer Letter* 2025; 634: 218058. (Corresponding author) 4. Yu-Qing Zhong, Xiao-Xu Zhu, Xi-Tai Huang, Yan-Ji Luo, Chen-Song Huang, Qiong-Cong Xu, Xiao-Yu Yin. Prediction of Clinically-Relevant Postoperative Pancreatic Fistula after pancreatoduodenectomy based on Multi-frequency Magnetic Resonance Elastography. *J Gastrointestinal Surg* 2025, 29(2), Page 101886. (Corresponding author) 5. Jia-Wei Zhou, Xi-Tai Huang, Jian-Peng Cai, Qiong-Cong Xu, Chen-Song Huang, Wei Chen, Xiao-Yu Yin. Two-drain versus three-train strategy in robotic-assisted pancreaticoduodenectomy: impact on complications. *Journal of Pancreatology* 2025;8(4):p 272-278. (Corresponding author) 6. Huang XT, Xie JZ, Cai JP, Xu QC, Chen W, Huang CS, Lin B, Lai JM, Liang LJ, Yin XY. Comparison of Short-Term Outcomes Between Robotic-Assisted and Open Pancreatoduodenectomy: A Retrospective Cohort Study With Inverse Probability of Treatment Weighting (IPTW) Analysis. *Int J Med Robot*; 2025;21(2):e70057. (Corresponding author) 7. Zhang, X., Huang, XT., Xie, JZ. Fu AQ, Chen W, Cai JP, Liang LJ, Yin XY. Prognostic significance of the number of hepatic lesions in multifocal intrahepatic cholangiocarcinoma after radical resection: an IPTW propensity-score analysis. *BMC Cancer* 2025;25,930. (Corresponding author) 8. Zhang X; Huang CS; Huang XT, Xu QC, Fu AQ, Cai JP, Lai JM, Yin XY. Development and interpretation of a pathomics-driven ensemble predictive model for prognosis of intrahepatic cholangiocarcinoma. *Eur J Surg Oncol*. 2025 Jun 28;51(9):110295. (Corresponding author) 9. Xin Zhang, Chen-Song Huang, Xi-Tai Huang, Ai-Qing Fu, Wei Chen, Jian-Peng Cai, Jia-Ming Lai, Xiao-Yu Yin. Machine Learning Algorithm-Based Tumor-Stroma Ratio Can Stratify the Prognosis of Intrahepatic Cholangiocarcinoma. *Journal of Surgical Research*. Volume 315, November 2025, Pages 184-193. (Corresponding author) 10. Shi YH, Liu ZD, Ma MJ, Zhao GY, Zhu YQ, Wang JQ, Yu YY, Huang XT, Ye JY, Li FX, Wang XY, Xu QC, Yin XY. Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism. *Adv Sci (Weinh)*. 2024 Sep 3:e2407069. doi: 10.1002/advs.202407069. (Corresponding author) 11. Zhu YQ, Huang Y, Shi YH, Huang CS, Zhao GY, Liu ZD, Ma MJ, Ye JY, Xu X, Liu Q, Huang XT, Wang JQ, Xu QC, Yin XY. Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. *Adv Sci (Weinh)*. 2024 Nov 3:e2406714. doi: 10.1002/advs.202406714. Epub ahead of print. PMID: 39488785. (Corresponding author) 12. Ma MJ, Shi YH, Liu ZD, Zhu YQ, Zhao GY, Ye JY, Li FX, Huang XT, Wang XY, Wang JQ, Xu QC, Yin XY. N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. *Oncogene*. 2024 Jun 24. (Corresponding author) 13. Liu ZD, Shi YH, Xu QC, Zhao GY, Zhu YQ, Li FX, Ma MJ, Ye JY, Huang XT, Wang XY, Xu X, Wang JQ, Zhao W, Yin XY. CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy. *Cancer Lett*. 2024 Mar 31;585:216640. doi: 10.1016/j.canlet.2024.216640. Epub 2024 Jan 28. PMID: 38290659. (Corresponding author) 14. Huang XT, Qu XF, Zhou JW, Cai JP, Xie JZ, Chen W, Chen LH, Yin XY. Robotic-assisted organ-preserving or parenchymal-sparing pancreatectomy in pancreatic benign or low-grade malignant tumors: a single institute’s experience. *J Robotic Surgery*. 2024:18:1. (Corresponding author) 15. Wang XY, Huang XT, Cai JP, Li B, Chen W, Huang CS, Yin XY. Robotic-Assisted Versus Open Hemi-Hepatectomy: A Propensity Score Analysis. *J Surg Res* 2024; https://doi.org/10.1016/j.jss.2024.09.001. (Corresponding author) 16. Wu X, Li JH, Xu L, Li YX, Zhu XX, Wang XY, Wu X, Zhao W, Ni X, Yin XY. SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. *Cell Death Differ*. 2023 May 15. doi: